Abraham R, Minor P, Dunn G, Modlin J F, Ogra P L
Dept. of Pediatrics, Children's Hospital, University of Texas Medical Branch, Galveston 77555-0531.
J Infect Dis. 1993 Nov;168(5):1105-9. doi: 10.1093/infdis/168.5.1105.
Fecal shedding of virulent revertant polioviruses was examined in isolates from infants previously immunized with > or = 1 dose of orally administered live attenuated polio vaccine (OPV) alone, enhanced-potency inactivated polio vaccine (EIPV) alone, or a combination of both. After administration of OPV alone, vaccine poliovirus serotypes were recovered in feces within 1 week and for as long as 31-60 days in 30%-80% of subjects after 1 or 2 doses and in 30%-50% after immunization with > or = 3 doses. No revertant poliovirus shedding was observed after OPV challenge in subjects immunized previously with > or = 3 doses of OPV. However, fecal shedding of revertant poliovirus after OPV challenge was observed in 50%-100% of subjects previously immunized with > or = 3 doses of the EIPV. These findings suggest that prior immunization with EIPV does not prevent fecal shedding of revertant polioviruses after subsequent reexposure to OPV.
对曾单独接种过≥1剂口服减毒活疫苗(OPV)、单独接种过高效灭活脊髓灰质炎疫苗(EIPV)或两种疫苗联合接种的婴儿分离株进行了毒性回复脊髓灰质炎病毒的粪便排出情况检测。单独接种OPV后,疫苗脊髓灰质炎病毒血清型在1周内出现在粪便中,1剂或2剂接种后,30%-80%的受试者粪便中病毒可持续排出31-60天,≥3剂接种后,30%-50%的受试者粪便中病毒可持续排出。之前接种过≥3剂OPV的受试者在接受OPV激发后未观察到回复脊髓灰质炎病毒排出。然而,之前接种过≥3剂EIPV的受试者在接受OPV激发后,50%-100%出现了回复脊髓灰质炎病毒的粪便排出。这些发现表明,先前接种EIPV并不能预防随后再次接触OPV后回复脊髓灰质炎病毒的粪便排出。